Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
05.05. | Median Technologies Is Moving Forward With the FDA Interactions for Its iBiopsy Lung Cancer Screening CADe/CADx Software as Medical Device | 170 | Business Wire | Median has received the FDA's feedback following the 513(g) regulatory submission for its iBiopsy LCS CADe/CADx Software as Medical Device.
Median will proceed through a 510(k) submission... ► Artikel lesen | |
03.05. | Median Technologies: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital as of April 30th, 2022 | 173 | Business Wire | Pursuant to article L-223-8 II of the French "code de Commerce" and 223-16 of the AMF's General Regulations.
Regulatory News:
Median Technologies (Paris:ALMDT):
Total number of shares
... ► Artikel lesen | |
21.04. | Median Technologies Reports Full-Year 2021 Results and Business Indicators for the First Quarter of 2022 | 201 | Business Wire | Record high revenue of €5.7 million in Q1 2022, up 9.2% compared with Q1 2021
Further growth in the order backlog to €62.3 million as of March 31, 2022, up 18.4% compared with March 31... ► Artikel lesen | |
MEDIAN TECHNOLOGIES Aktie jetzt für 0€ handeln | |||||
08.04. | Median Technologies: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital as of March 31st, 2022 | 294 | Business Wire | Pursuant to article L-223-8 II of the French "code de Commerce" and 223-16 of the AMF's General Regulations.
Regulatory News:
Median Technologies (Paris:ALMDT):
Total number of shares
... ► Artikel lesen | |
25.03. | Median Technologies Brings Forward Its 2021 Annual Results Publication to April 21, 2022 | 269 | Business Wire | Regulatory News:
Median Technologies (ALMDT:PA) (Paris:ALMDT) announces today that the company will publish its 2021 annual results on April 21, 2022 after trading. The 2021 annual results publication... ► Artikel lesen | |
22.03. | Median Technologies Announces Design Completion of its iBiopsy Lung Cancer Screening End-to-end CADe/CADx Software as Medical Device (SaMD) with Outstanding Sensitivity & Specificity Performance | 209 | Business Wire | iBiopsy Lung Cancer Screening (LCS) CADe/CADx1outstanding performance reaches 94.7% sensitivity2 at 93.3% specificity3, based on a cohort of 1,760 patients
With such performance, iBiopsy... ► Artikel lesen | |
09.03. | Median Technologies: Disclosure of total number of voting rights and number of shares in the capital as of February 28th, 2022 | 199 | Business Wire | Pursuant to article L-223-8 II of the French "code de Commerce" and 223-16 of the AMF's General Regulations.
Regulatory News:
Median Technologies (Paris:ALMDT):
Total number of shares
... ► Artikel lesen | |
03.03. | Median Technologies Files FDA 513(g) Regulatory Submission for iBiopsy Lung Cancer Screening CADe/CADx Software as Medical Device | 207 | Business Wire | 513(g) submission is a key milestone that marks the initiation of Median's interactions with the FDA.
513(g) submission will allow Median Technologies to determine the best FDA regulatory... ► Artikel lesen | |
01.03. | Median Technologies to Participate in the Cowen's 42nd Annual Health Care Conference | 206 | Business Wire | Regulatory News:
Median Technologies (Paris: ALMDT), will be participating in the Cowen's 42nd Annual Health Care Conference, taking place virtually on March 7-9, 2022.
Fredrik Brag, Median's... ► Artikel lesen | |
08.02. | Median Technologies: Disclosure of total number of voting rights and number of shares in the capital as of January 31st, 2022 | 245 | Business Wire | Pursuant to article L-223-8 II of the French "code de Commerce" and 223-16 of the AMF's General Regulations.
Regulatory News:
Median Technologies (Paris:ALMDT):
Total number of shares
... ► Artikel lesen | |
17.01. | Median Technologies Announces 2021 Revenue of €20.5 Million, Up 52%, and a Strengthened Cash Position of €39 Million | 259 | Business Wire | Revenue of €20.5 million as of December 31, 2021, up 52% versus 2020 (€13.5 million).
Order backlog growth to €58 million as of December 31, 2021.
Cash and cash equivalents of €39... ► Artikel lesen | |
14.01. | Median Technologies: Half Year Liquidity Contract Statement | 384 | Business Wire | Regulatory News:
Under the liquidity contract entrusted by Median Technologies (Paris:ALMDT) (FR0011049824 ALMDT FP) to TP ICAP (Europe), the following resources were listed in the liquidity account... ► Artikel lesen | |
10.01. | Median Technologies: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital as of December 31st, 2021 | 250 | Business Wire | Pursuant to article L-223-8 II of the French "code de Commerce" and 223-16 of the AMF's General Regulations.
Regulatory News:
Median Technologies (Paris:ALMDT):
Total number of shares
... ► Artikel lesen | |
05.01. | Median Technologies Announces Outstanding Lung Nodule Detection (CADe1) Performance for iBiopsy Lung Cancer Screening | 354 | Business Wire | iBiopsy Lung Cancer Screening (LCS) detection performance reaches 94.9% sensitivity for a false positive rate of 1 per CT scan, a performance superior to that of lung CADe systems currently on... ► Artikel lesen | |
04.01. | Median Technologies: Financial Communications Schedule for the First Half of 2022 | 262 | Business Wire | Regulatory News:
Median Technologies (Paris:ALMDT) (ALMDT:PA), announces the publication date for its 2021 results:
Publication
Date
2021 results
April 26, 2022*
... ► Artikel lesen | |
06.12.21 | Median Technologies: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital as of November 30th, 2021 | 252 | Business Wire | Pursuant to article L-223-8 II of the French "code de Commerce" and 223-16 of the AMF's General Regulations.
Regulatory News:
Median Technologies (Paris:ALMDT):
Total number of shares
... ► Artikel lesen | |
23.11.21 | Median Technologies Announces New Outstanding Performance for its iBiopsy Lung Cancer Screening CADx1 With a Focus on Stage 1 Lung Cancer Characterization | 345 | Business Wire | iBiopsy's Lung Cancer Screening performance (LCS) for stage 1 lung cancer reaches 93.1% sensitivity at 96.2% specificity.
These results are critical for lung cancer characterization at... ► Artikel lesen | |
08.11.21 | Median Technologies: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital as of October 31st, 2021 | 276 | Business Wire | Pursuant to article L-223-8 II of the French "code de Commerce" and 223-16 of the AMF's General Regulations.
Regulatory News:
Median Technologies (Paris:ALMDT):
Total number of shares
... ► Artikel lesen | |
21.10.21 | Median Technologies Reports on Its 2021 Half-Year Results and Its Q3 2021 Business Activity Indicators | 313 | Business Wire | Business continues to grow at a sustained pace in the first half of 2021
Two highly impactful announcements for iBiopsy and iCRO business units during Q3, 2021
Third quarter revenue... ► Artikel lesen | |
13.10.21 | Median Technologies to Host a Live Webcast and Provide a Company Update on October 25th, 2021 | 280 | Business Wire | Regulatory News:
Median Technologies (ALMDT:PA) announced today that Fredrik Brag, CEO and founder of Median Technologies, will provide a company update on October 25th, 2021 at 6:00 pm CEST during... ► Artikel lesen |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
SAP | 92,17 | +2,15 % | SAP-Konkurrenten Microsoft, Oracle und Salesforce (noch) im Korrekturmodus. | Am Freitag (13.05.) zeigte der Technologiebereich ein Aufbäumen. Nach den veritablen Kursverlusten der letzten Wochen kam dieser Erholungsversuch gerade zur richtigen Zeit. Doch wie immer stellt sich... ► Artikel lesen | |
TEAMVIEWER | 12,775 | +4,97 % | Varta nach den Zahlen. TeamViewer um Boden bemüht. Zalando zeigt Reaktion. | Unseren drei heutigen Protagonisten Zalando, TeamViewer und Varta durchlaufen aktuell schwierige Phasen. Während sich die Aktie von TeamViewer bereits seit Monaten in einer zähen Bodenbildung ergeht... ► Artikel lesen | |
ZOOMINFO TECHNOLOGIES | 40,200 | +0,25 % | ZoomInfo Technologies Inc. - 8-K, Current Report | ||
ANAPLAN | 64,79 | +0,26 % | PRESSESPIEGEL/Unternehmen: MERCEDES, RWE, LUFTFAHRTVERSICHERER, DOUGLAS, IKB, MV WERFTEN, ARIANESPACE, ANAPLAN/THOMA BRAVO | DJ PRESSESPIEGEL/Unternehmen
Die wirtschaftsrelevanten Themen aus den Medien, zusammengestellt von Dow Jones Newswires.
MERCEDES - Mercedes hat an seinem Standort in Sindelfingen Kurzarbeit... ► Artikel lesen | |
MICROSOFT | 242,85 | +0,39 % | Schlüsselloch: Hinter den Kulissen bei Microsofts Activision Blizzard-Deal | ||
SUSE | 26,820 | -3,87 % | DGAP-NVR: SUSE S.A.: Veröffentlichung der Gesamtzahl der Stimmrechte nach § 41 WpHG mit dem Ziel der europaweiten Verbreitung | DGAP Gesamtstimmrechtsmitteilung: SUSE S.A.
/ Veröffentlichung der Gesamtzahl der Stimmrechte
SUSE S.A.: Veröffentlichung der Gesamtzahl der Stimmrechte nach § 41 WpHG mit dem Ziel der... ► Artikel lesen | |
MONDAY.COM | 115,51 | +2,41 % | Monday.com: Cloud-basierte Software-Plattform wächst enorm, Verlust allerdings auch | TEL AVIV (IT-Times) - das israelische Softwareunternehmen Monday.com hat heute seine Ergebnisse für das Auftaktquartal des Geschäftsjahres 2022 veröffentlicht und ein starkes Umsatzwachstum gezeigt.... ► Artikel lesen | |
NEMETSCHEK | 64,84 | +2,14 % | Dividendenbekanntmachungen (13.05.2022) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) A10 NETWORKS INC US0021211018 0,05 USD 0,0481 EUR ADIDAS AG DE000A1EWWW0 - 3,3 EUR AGCO CORPORATION US0010841023 0,24 USD 0,2311... ► Artikel lesen | |
BUMBLE | 28,720 | +1,41 % | Bumble-Aktie im Aufwind: Dating-App gewinnt mehr zahlende Nutzer | Von Karishma VanjaniBarron'sÜbersetzung: Thomas SteerDie Ergebnisse von Bumble fielen besser aus als erwartet, da die Dating-App im letzten Quartal mehr zahlende Nutzer verzeichnen konnte. Ein Grund... ► Artikel lesen | |
SENTINELONE | 24,460 | +4,37 % | SentinelOne's DataSet Kubernetes Explorer aims to centralize container monitoring | ||
MATTERPORT | 5,590 | +1,27 % | Matterport Inc: Matterport Celebrates International Museum Day with Access to Stunning Virtual Tours | ||
SOFTWARE AG | 30,160 | +0,94 % | Dividendenbekanntmachungen (18.05.2022) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ADTRAN INC US00738A1060 0,09 USD 0,0852 EUR ALLIED MOTION TECHNOLOGIES INC US0193301092 0,025 USD 0,0236 EUR ARIS WATER SOLUTIONS... ► Artikel lesen | |
PUBMATIC | 22,810 | +3,49 % | PubMatic schließt CTV-Partnerschaften mit Funke und anderen Unternehmen | ||
DATTO | 33,750 | +0,12 % | Datto Non-GAAP EPS of $0.14 beats by $0.01, revenue of $170.8M beats by $2.36M | ||
SECUNET SECURITY NETWORKS | 337,00 | +1,66 % | DGAP-Adhoc: secunet Security Networks AG: secunet Security Networks übernimmt SysEleven GmbH | DGAP-Ad-hoc: secunet Security Networks AG / Schlagwort(e): Firmenübernahme
secunet Security Networks AG übernimmt SysEleven GmbH
17.05.2022 / 13:06 CET/CEST
Veröffentlichung einer Insiderinformation... ► Artikel lesen |